Exclusive-Biden to nominate U.S. surgeon general to join WHO executive board -official
Reuters
Published Oct 04, 2022 02:43PM ET
Updated Oct 04, 2022 08:45PM ET
By Jeff Mason
WASHINGTON (Reuters) -President Joe Biden intends to nominate Surgeon General Vivek Murthy to be the U.S. representative on the World Health Organization's executive board, administration officials told Reuters on Tuesday.
Murthy has served as the top U.S. doctor under Biden and under former President Barack Obama. He will continue in that role while taking on the WHO position, if confirmed by the U.S. Senate.
"With his experience and expertise, the president is confident that Dr. Murthy will build on his commitment to an era of relentless diplomacy by representing our nation on the world stage," one official said.
"Rejoining the WHO requires an experienced and seasoned physician and public health expert," who can expand on the U.S. commitment to global health, the official said. "Dr. Murthy is the perfect person for that."
Upon taking office in January 2021, Biden declared that the United States would reengage with the WHO after his predecessor, former President Donald Trump, said in 2020 that the country would withdraw from the organization because of its handling of the coronavirus pandemic.
"If confirmed, I will continue to elevate U.S leadership on the global stage and ensure public health is at the forefront of our planning and preparation for global challenges," Murthy said in a statement provided to Reuters.
A second administration official said Murthy would remain in Washington, where he lives with his wife and two children, but travel to Geneva "whenever necessary to fulfill the responsibilities of this role."
The WHO's executive board has 34 members who serve 3-year terms. Its purpose, according to the organization's website, is to prepare an agenda for and implement policies by the World Health Assembly, which is made up of the WHO member states. The U.S. has not had a Senate-confirmed representative on the board since 2020.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.